Human platelet lysate refers to a blood product that is generated from platelets of healthy human blood donors. It contains high levels of growth factors that support cell growth. Human platelet lysates find extensive applications as a substitute for fetal bovine serum in cell culture processes. It provides nutrients and growth factors required to support cell growth, proliferation, and differentiation in therapeutic applications. Human platelet lysates have gained increasing acceptance as they provide xenogeneic-free and reproducible cell culture conditions.
The global Human Platelet Lysate Market is estimated to be valued at US$ 53.0 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Regenerative medicine utilizes platelet lysates for cell expansion processes as it helps improve cell viability and proliferation. According to the International Society for Stem Cell Research, over 800 clinical trials using stem cell therapies were registered or approved between 2014 to 2018. Increasing R&D investments by biotechnology companies and academic medical centers in stem cell-based therapies will further propel the demand for human platelet lysates. Additionally, continuous support from regulatory bodies to develop advanced therapy medicinal products using platelet lysates is also anticipated to fuel the market growth.
Segment Analysis
There are two major segments in the human platelet lysate market – autologous platelet lysate and allogenic platelet lysate. The allogenic platelet lysate segment currently dominates the market and is expected to continue its dominance over the forecast period. This is because allogenic platelet lysate can be produced in bulk quantities using a standard operating procedure, making it readily available and cost-effective. Autologous platelet lysate needs to be produced individually for each patient which increases production cost and complexity.
PEST Analysis
Political: The regulations surrounding human-derived products are becoming more stringent to ensure safety and efficacy. Complying with changing regulations impacts the research and production activities of players.
Economic: The global platelet lysate market is expected to experience healthy growth due to increasingstem cell therapy and regenerative medicine research.However, high production costs and pricing pressure from alternatives impact market prospects.
Social: With rising incidence of chronic diseases and an aging population, demand for advanced treatment solutions is increasing. Platelet lysates are being extensively researched for applications in wound healing, cancer, and other therapeutic areas.
Technological: Players are focusing on developing improved production techniques to lower costs and ensure reproducible quality of platelet lysates. Automation and single-use bioprocessing offer opportunities for standardized mass production.
Key Takeaways
The Global Human Platelet Lysate Market Demand is expected to witness high growth over the forecast period due to the increasing demand for platelet lysate in cell-culture media.
Regional analysis: North America dominates the global human platelet lysate market currently due to extensive research activities in the region. However, Asia Pacific is expected to witness the highest growth fueled by increasing healthcare investment, emerging biotech industry, and growing medical tourism in countries such as China and India.
Key players: Key players operating in the human platelet lysate market are STEMCELL Technologies Inc., Merck KGaA, Mill Creek Life Sciences, Merck & Co., Inc, AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH, Cook Regentec, Life Science Group Ltd., BBI Solutions, Regenexx, Thermo Fisher Scientific. Players are focused on developing new production technologies to mass-produce platelet lysates at lower costs.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it